🎁
DIWALI SPECIAL

20% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo
Mkt Cap
₹1.18 L Cr.
P/E (TTM)
56.41
Open
₹8,152.00
Day's Range
₹8,100.00 – ₹8,240.50
52W Range
₹6,696.50 – ₹9,070.50
Div Yield
0.26%
EPS (TTM)
₹145.26
Book Value
₹659.33

APOLLO HOSPITALS ENTER L Quarterly Results

In Aug 2026, APOLLO HOSPITALS ENTER L reported revenue of ₹7,044 crore (up 0.0% on the prior quarter) and net profit of ₹581 crore (up 0.0%). 55 reported quarters are tabulated below.

Updated Source: NSE & BSE company filingsNifty 50 constituent
Latest quarter revenue
₹7,044 Cr
+0.0% vs prior
EBITDA
₹1,092 Cr
+0.0% vs prior
Operating margin
15.51%
Profit after tax
₹581 Cr
+0.0% vs prior
Net margin
8.24%
EPS
₹40.39
Latest quarter
Aug 2026
Quarters reported
55

APOLLO HOSPITALS ENTER L revenue and profit trend

The quickest view of reported quarterly business performance. Revenue and profit use separate scales.

APOLLO HOSPITALS ENTER L quarterly results

Reported quarterly performance for APOLLO HOSPITALS ENTER L, oldest to newest. Figures in ₹ crore unless a row states otherwise.

APOLLO HOSPITALS ENTER L quarterly profit and loss statement. Figures in ₹ crore unless a row states otherwise.
Line itemMar 2025May 2025Jun 2025Aug 2025Sept 2025Nov 2025Dec 2025Feb 2026Mar 2026May 2026Jun 2026Aug 2026
Revenue from Operations5,5925,5925,8425,8426,3046,3046,4776,4776,6066,6067,0447,044
Sales Growth YoY %13.11%13.11%14.88%14.88%12.78%12.78%17.2%17.2%18.12%18.12%20.56%20.56%
Other Income616140405555535344444949
Total Income5,6535,6535,8825,8826,3586,3586,5306,5306,6496,6497,0927,092
Cost of Goods Sold (COGS)2,9292,9293,0483,0483,2443,2443,3823,3823,4023,4023,5973,597
Cost of Materials Consumed694694740740779779745745777777829829
Purchases of Stock-in-Trade2,2442,2442,3162,3162,4652,4652,6632,6632,6132,6132,7682,768
Changes in Inventories-9-9-8-800-25-25121200
Gross Profit2,6642,6642,7952,7953,0603,0603,0953,0953,2043,2043,4463,446
Gross Margin %47.63%47.63%47.83%47.83%48.54%48.54%47.78%47.78%48.5%48.5%48.93%48.93%
Total Operating Expenses1,8941,8941,9431,9432,1192,1192,1302,1302,1932,1932,3542,354
Employee Benefit Expense725725713713767767749749772772796796
Other Expenses1,1691,1691,2301,2301,3521,3521,3811,3811,4211,4211,5591,559
EBITDA7707708528529419419659651,0111,0111,0921,092
OPM %13.76%13.76%14.58%14.58%14.93%14.93%14.9%14.9%15.31%15.31%15.51%15.51%
Total Non-Operating Expenses326326323323327327313313344344356356
Depreciation & Amortisation211211215215218218219219224224235235
Finance Costs115115108108110110113113119119120120
Exceptional Items (Before Tax)000000-19-190000
Profit Before Tax (PBT)505505569569668668667667711711785785
Tax Expense101101142142181181166166170170188188
Current Tax119119125125162162147147196196210210
Deferred Tax-18-18171719191919-26-26-22-22
Effective Tax %20%20%24.9%24.9%27.03%27.03%24.84%24.84%23.92%23.92%23.99%23.99%
Total Profit for Period415415441441494494516516551551610610
Less: Non-controlling Interests2525881717141422223030
Net Profit (Owner's PAT)390390433433477477502502529529581581
Net Profit Margin %6.97%6.97%7.41%7.41%7.57%7.57%7.75%7.75%8.01%8.01%8.24%8.24%
PAT Growth YoY %53.51%53.51%41.81%41.81%25.98%25.98%34.92%34.92%35.86%35.86%34.17%34.17%
Earnings Per Share (EPS)₹27.1₹27.1₹30.1₹30.1₹33.19₹33.19₹34.93₹34.93₹36.81₹36.81₹40.39₹40.39
Diluted Shares Outstanding (Cr.)141414141414141414141414
Profit/Loss from Associates1111141466151510101313
Other Comprehensive Income (Net of Tax)-3-3665757-0-0-4-444
Expenses5,1485,1485,3135,3135,6905,6905,8635,8635,9385,9386,3076,307
Material Cost %12.42%12.42%12.67%12.67%12.35%12.35%11.5%11.5%11.77%11.77%11.77%11.77%
Employee Cost %12.96%12.96%12.2%12.2%12.16%12.16%11.56%11.56%11.69%11.69%11.3%11.3%
Other Cost %20.91%20.91%21.05%21.05%21.45%21.45%21.32%21.32%21.5%21.5%22.13%22.13%
Interest Coverage (x)4.874.875.885.886.66.66.636.636.66.67.127.12

Showing the most recent 12 of 55 reported periods.

How this is calculated

Figures are as reported to NSE/BSE by the company. Consolidated is shown where the company reports it, standalone otherwise; the basis is labelled on the table. Growth is computed against the same quarter of the previous year (YoY) and the immediately preceding quarter (QoQ).

Index membership reflects the Nifty 100 as published by NSE Indices, effective 2026-03-30.

APOLLO HOSPITALS ENTER L: frequently asked questions

What was APOLLO HOSPITALS ENTER L's revenue in Aug 2026?

APOLLO HOSPITALS ENTER L reported revenue of ₹7,044 crore in Aug 2026, up 0.0% on the previous quarter.

What was APOLLO HOSPITALS ENTER L's profit in Aug 2026?

APOLLO HOSPITALS ENTER L reported a net profit of ₹581 crore in Aug 2026, up 0.0% on the previous quarter.

What is APOLLO HOSPITALS ENTER L's EPS?

APOLLO HOSPITALS ENTER L reported earnings per share of ₹40.39 for Aug 2026.

What is APOLLO HOSPITALS ENTER L's operating margin?

APOLLO HOSPITALS ENTER L's operating margin for Aug 2026 was 15.51%.

When did APOLLO HOSPITALS ENTER L last report results?

The most recent reported quarter shown here is Aug 2026. 55 quarters of history are tabulated on this page.

Are these figures consolidated or standalone?

Consolidated figures are shown wherever the company reports them, and standalone otherwise. The basis in use is labelled on the statement table.

Comparing quarterly results across companies is more useful than reading one in isolation — the peer links above open the same view for APOLLO HOSPITALS ENTER L’s closest listed competitors.

Disclaimer

The data, ratios and commentary about APOLLO HOSPITALS ENTER. L (APOLLOHOSP) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.